These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 31493514)

  • 1. Flecainide: Electrophysiological properties, clinical indications, and practical aspects.
    Paolini E; Stronati G; Guerra F; Capucci A
    Pharmacol Res; 2019 Oct; 148():104443. PubMed ID: 31493514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flecainide in clinical practice.
    Basza M; Maciejewski C; Bojanowicz W; Balsam P; Grabowski M; Mitkowski P; Kempa M; Kowalski O; Kalarus Z; Jaguszewski M; Lubiński A; Daniłowicz-Szymanowicz L; Szumowski Ł; Sterliński M; Kołtowski Ł
    Cardiol J; 2023; 30(3):473-482. PubMed ID: 36908162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous Flecainide for Emergency Department Management of Acute Atrial Fibrillation.
    Markey GC; Salter N; Ryan J
    J Emerg Med; 2018 Mar; 54(3):320-327. PubMed ID: 29269083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple targets for flecainide action: implications for cardiac arrhythmogenesis.
    Salvage SC; Chandrasekharan KH; Jeevaratnam K; Dulhunty AF; Thompson AJ; Jackson AP; Huang CL
    Br J Pharmacol; 2018 Apr; 175(8):1260-1278. PubMed ID: 28369767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Flecainide for the Treatment of Atrial Fibrillation.
    Echt DS; Ruskin JN
    Am J Cardiol; 2020 Apr; 125(7):1123-1133. PubMed ID: 32044037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flecainide How and When: A Practical Guide in Supraventricular Arrhythmias.
    Lavalle C; Magnocavallo M; Straito M; Santini L; Forleo GB; Grimaldi M; Badagliacca R; Lanata L; Ricci RP
    J Clin Med; 2021 Apr; 10(7):. PubMed ID: 33918105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased atrial effectiveness of flecainide conferred by altered biophysical properties of sodium channels.
    O' Brien S; Holmes AP; Johnson DM; Kabir SN; O' Shea C; O' Reilly M; Avezzu A; Reyat JS; Hall AW; Apicella C; Ellinor PT; Niederer S; Tucker NR; Fabritz L; Kirchhof P; Pavlovic D
    J Mol Cell Cardiol; 2022 May; 166():23-35. PubMed ID: 35114252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ventricular arrhythmia and death among atrial fibrillation patients using anti-arrhythmic drugs.
    Friberg L
    Am Heart J; 2018 Nov; 205():118-127. PubMed ID: 30236980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased capture threshold in permanent His-bundle pacing associated with flecainide.
    Jiang M; Wasserlauf J; Knight BP; Verma N
    Pacing Clin Electrophysiol; 2020 Apr; 43(4):360-363. PubMed ID: 32010978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arrhythmias in Pregnancy.
    Tamirisa KP; Elkayam U; Briller JE; Mason PK; Pillarisetti J; Merchant FM; Patel H; Lakkireddy DR; Russo AM; Volgman AS; Vaseghi M
    JACC Clin Electrophysiol; 2022 Jan; 8(1):120-135. PubMed ID: 35057977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consequences of AV blockade omission in flecainide therapy.
    Ferrante JA; Rizvi M; Sakaan S; Eick J; Cutshall BT
    Nurse Pract; 2021 Jul; 46(7):10-13. PubMed ID: 34138806
    [No Abstract]   [Full Text] [Related]  

  • 12. Flecainide Toxicity Resulting in Pacemaker Latency and Intermittent Failure to Capture.
    Suffredini JM; Rutland J; Akpunonu P; Baum R; Catanzaro J; Elayi CS
    Am J Case Rep; 2019 Aug; 20():1279-1283. PubMed ID: 31467262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Atrial fibrillation. A presentation of 2 cases].
    Roguera Sopena M; Sabidó Sánchez L; Villuendas Sabaté R; Del Alcázar Muñoz R
    An Pediatr (Engl Ed); 2020 Jan; 92(1):47-49. PubMed ID: 30803827
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute management of paroxysmal atrial fibrillation with beta-blockers plus intravenous flecainide using the real-world Chios registry (BETAFLEC-CHIOS).
    Kartalis A; Afendoulis D; Moutafi M; Voutas P; Papagiannis N; Garoufalis S; Kartalis N; Smyrnioudis N; Andrikopoulos G; Didagelos M
    Kardiol Pol; 2023; 81(4):394-397. PubMed ID: 36446070
    [No Abstract]   [Full Text] [Related]  

  • 15. Flecainide in Ventricular Arrhythmias: From Old Myths to New Perspectives.
    Lavalle C; Trivigno S; Vetta G; Magnocavallo M; Mariani MV; Santini L; Forleo GB; Grimaldi M; Badagliacca R; Lanata L; Ricci RP
    J Clin Med; 2021 Aug; 10(16):. PubMed ID: 34441994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of antiarrhythmic effects of flecainide in catecholaminergic polymorphic ventricular tachycardia.
    Watanabe H; Steele DS; Knollmann BC
    Circ Res; 2011 Sep; 109(6):712-3. PubMed ID: 21885838
    [No Abstract]   [Full Text] [Related]  

  • 17. A very wide complex tachycardia.
    Kheiri B; Vedantham V; Scheinman M
    Heart Rhythm; 2023 Jun; 20(6):937-939. PubMed ID: 37245898
    [No Abstract]   [Full Text] [Related]  

  • 18. [How to: clinical use of antiarrhythmic drugs].
    Hillmann HAK; Betz K; Linz D; Duncker D
    Herzschrittmacherther Elektrophysiol; 2023 Mar; 34(1):82-90. PubMed ID: 36692540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-arrhythmic investigations in large animal models of atrial fibrillation.
    Saljic A; Jespersen T; Buhl R
    Br J Pharmacol; 2022 Mar; 179(5):838-858. PubMed ID: 33624840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flecainide poisoning and prolongation of elimination due to alkalinization.
    McCabe DJ; Walsh RD; Georgakakos PK; Radke JB; Wilson BZ
    Am J Emerg Med; 2022 Jun; 56():394.e1-394.e4. PubMed ID: 35287973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.